Essay on fMRI draws criticism and praise from psychologists and others
To the Editor:
I am not a social scientist, nor am I a practitioner of functional magnetic resonance imaging (fMRI), but I am expert in MRI, so I feel qualified to offer unbiased criticism of your essay in the July 19, 2004, issue of
Let me be explicit about the ways in which you were wrong or wrong-headed:
1) Putting "fake" in the title is simply irresponsible, and I hope you get the avalanche of mail that you deserve about this.
2) You make the blanket statement that fMRI is not ...
The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.
View this Issue
In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.
In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.
In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.
In this webinar, Andre Mueller will discuss how scientists characterize therapeutic proteins in different formulations and spot the effects of excipients on protein stability.
The ranking places Refeyn among a cohort of high-growth UK technology firms spanning sectors including the life sciences, energy and sustainability, telecommunications, and digital technology.
Partnership unites AI and single cell technology to map immune dysfunction and improve drug discovery and development outcomes
Designed to balance ease of use, cost efficiency, and reproducible data, which are critical requirements for successful high-throughput screening campaigns
Automated Twist NGS library preparation workflows available on SPT Labtech’s firefly platform via the firefly cloud
